All CTCAE (v. 6.0) grade 2-4 immune-related adverse events research hub

Rituximab for Treatment of Checkpoint Inhibitor Induced Immune Related Adverse Events

This study is looking at a medicine called rituximab. It's for people who have unwanted side effects from certain cancer treatments, specifically immunotherapy. Researchers want to see if rituximab can help reduce these side effects, which can sometimes be serious.